Trials / Conditions / HER 2 Negative Breast Cancer
HER 2 Negative Breast Cancer
6 registered clinical trials studyying HER 2 Negative Breast Cancer — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer NCT07102940 | George Washington University | Phase 2 |
| Recruiting | A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negat NCT07520760 | Sun Yat-sen University | Phase 2 |
| Recruiting | Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer NCT05398861 | Henan Cancer Hospital | Phase 2 |
| Recruiting | Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation NCT05761470 | Ying Lin | Phase 2 |
| Unknown | Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Bre NCT03799692 | Fudan University | Phase 4 |
| Completed | Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in F NCT03462251 | iOMEDICO AG | Phase 3 |